909 related articles for article (PubMed ID: 11586359)
1. A forkhead-domain gene is mutated in a severe speech and language disorder.
Lai CS; Fisher SE; Hurst JA; Vargha-Khadem F; Monaco AP
Nature; 2001 Oct; 413(6855):519-23. PubMed ID: 11586359
[TBL] [Abstract][Full Text] [Related]
2. Localisation of a gene implicated in a severe speech and language disorder.
Fisher SE; Vargha-Khadem F; Watkins KE; Monaco AP; Pembrey ME
Nat Genet; 1998 Feb; 18(2):168-70. PubMed ID: 9462748
[TBL] [Abstract][Full Text] [Related]
3. Deciphering the genetic basis of speech and language disorders.
Fisher SE; Lai CS; Monaco AP
Annu Rev Neurosci; 2003; 26():57-80. PubMed ID: 12524432
[TBL] [Abstract][Full Text] [Related]
4. Genetics. First gene linked to speech identified.
Balter M
Science; 2001 Oct; 294(5540):32. PubMed ID: 11588230
[No Abstract] [Full Text] [Related]
5. Molecular evolution of FOXP2, a gene involved in speech and language.
Enard W; Przeworski M; Fisher SE; Lai CS; Wiebe V; Kitano T; Monaco AP; Pääbo S
Nature; 2002 Aug; 418(6900):869-72. PubMed ID: 12192408
[TBL] [Abstract][Full Text] [Related]
6. Intracellular distribution of a speech/language disorder associated FOXP2 mutant.
Mizutani A; Matsuzaki A; Momoi MY; Fujita E; Tanabe Y; Momoi T
Biochem Biophys Res Commun; 2007 Feb; 353(4):869-74. PubMed ID: 17196932
[TBL] [Abstract][Full Text] [Related]
7. FOXP2 as a molecular window into speech and language.
Fisher SE; Scharff C
Trends Genet; 2009 Apr; 25(4):166-77. PubMed ID: 19304338
[TBL] [Abstract][Full Text] [Related]
8. The SPCH1 region on human 7q31: genomic characterization of the critical interval and localization of translocations associated with speech and language disorder.
Lai CS; Fisher SE; Hurst JA; Levy ER; Hodgson S; Fox M; Jeremiah S; Povey S; Jamison DC; Green ED; Vargha-Khadem F; Monaco AP
Am J Hum Genet; 2000 Aug; 67(2):357-68. PubMed ID: 10880297
[TBL] [Abstract][Full Text] [Related]
9. Language fMRI abnormalities associated with FOXP2 gene mutation.
Liégeois F; Baldeweg T; Connelly A; Gadian DG; Mishkin M; Vargha-Khadem F
Nat Neurosci; 2003 Nov; 6(11):1230-7. PubMed ID: 14555953
[TBL] [Abstract][Full Text] [Related]
10. Structural analysis of disease-causing mutations in the P-subfamily of forkhead transcription factors.
Banerjee-Basu S; Baxevanis AD
Proteins; 2004 Mar; 54(4):639-47. PubMed ID: 14997560
[TBL] [Abstract][Full Text] [Related]
11. FOXP2 is not a major susceptibility gene for autism or specific language impairment.
Newbury DF; Bonora E; Lamb JA; Fisher SE; Lai CS; Baird G; Jannoun L; Slonims V; Stott CM; Merricks MJ; Bolton PF; Bailey AJ; Monaco AP;
Am J Hum Genet; 2002 May; 70(5):1318-27. PubMed ID: 11894222
[TBL] [Abstract][Full Text] [Related]
12. The medaka FoxP2, a homologue of human language gene FOXP2, has a diverged structure and function.
Itakura T; Chandra A; Yang Z; Xue X; Wang B; Kimura W; Hikosaka K; Inohaya K; Kudo A; Uezato T; Miura N
J Biochem; 2008 Mar; 143(3):407-16. PubMed ID: 18079162
[TBL] [Abstract][Full Text] [Related]
13. [Genetics of specific language impairments].
Bonneau D; Verny C; Uzé J
Arch Pediatr; 2004 Oct; 11(10):1213-6. PubMed ID: 15475279
[TBL] [Abstract][Full Text] [Related]
14. Absence of causative mutations and presence of autism-related allele in FOXP2 in Japanese autistic patients.
Li H; Yamagata T; Mori M; Momoi MY
Brain Dev; 2005 Apr; 27(3):207-10. PubMed ID: 15737702
[TBL] [Abstract][Full Text] [Related]
15. Identification of FOXP2 truncation as a novel cause of developmental speech and language deficits.
MacDermot KD; Bonora E; Sykes N; Coupe AM; Lai CS; Vernes SC; Vargha-Khadem F; McKenzie F; Smith RL; Monaco AP; Fisher SE
Am J Hum Genet; 2005 Jun; 76(6):1074-80. PubMed ID: 15877281
[TBL] [Abstract][Full Text] [Related]
16. FOXP2 variants in 14 individuals with developmental speech and language disorders broaden the mutational and clinical spectrum.
Reuter MS; Riess A; Moog U; Briggs TA; Chandler KE; Rauch A; Stampfer M; Steindl K; Gläser D; Joset P; ; Krumbiegel M; Rabe H; Schulte-Mattler U; Bauer P; Beck-Wödl S; Kohlhase J; Reis A; Zweier C
J Med Genet; 2017 Jan; 54(1):64-72. PubMed ID: 27572252
[TBL] [Abstract][Full Text] [Related]
17. Deletion of 7q31.1 supports involvement of FOXP2 in language impairment: clinical report and review.
Lennon PA; Cooper ML; Peiffer DA; Gunderson KL; Patel A; Peters S; Cheung SW; Bacino CA
Am J Med Genet A; 2007 Apr; 143A(8):791-8. PubMed ID: 17330859
[TBL] [Abstract][Full Text] [Related]
18. FOXP2: novel exons, splice variants, and CAG repeat length stability.
Bruce HA; Margolis RL
Hum Genet; 2002 Aug; 111(2):136-44. PubMed ID: 12189486
[TBL] [Abstract][Full Text] [Related]
19. Speech, prosody, and voice characteristics of a mother and daughter with a 7;13 translocation affecting FOXP2.
Shriberg LD; Ballard KJ; Tomblin JB; Duffy JR; Odell KH; Williams CA
J Speech Lang Hear Res; 2006 Jun; 49(3):500-25. PubMed ID: 16787893
[TBL] [Abstract][Full Text] [Related]
20. Unravelling neurogenetic networks implicated in developmental language disorders.
Vernes SC; Fisher SE
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1263-9. PubMed ID: 19909259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
